Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 254

1.

The proteolytically stable peptidomimetic Pam-(Lys-βNSpe)6-NH2 selectively inhibits human neutrophil activation via formyl peptide receptor 2.

Skovbakke SL, Heegaard PM, Larsen CJ, Franzyk H, Forsman H, Dahlgren C.

Biochem Pharmacol. 2015 Jan 15;93(2):182-95. doi: 10.1016/j.bcp.2014.11.004. Epub 2014 Nov 14.

PMID:
25462815
[PubMed - in process]
2.

Structural changes of the ligand and of the receptor alters the receptor preference for neutrophil activating peptides starting with a formylmethionyl group.

Forsman H, Winther M, Gabl M, Skovbakke SL, Boulay F, Rabiet MJ, Dahlgren C.

Biochim Biophys Acta. 2015 Jan;1853(1):192-200. doi: 10.1016/j.bbamcr.2014.10.021. Epub 2014 Oct 30.

PMID:
25447672
[PubMed - indexed for MEDLINE]
3.

Olfactomedin-4 autoantibodies give unusual c-ANCA staining patterns with reactivity to a subpopulation of neutrophils.

Amirbeagi F, Thulin P, Pullerits R, Pedersen B, Andersson BA, Dahlgren C, Welin A, Bylund J.

J Leukoc Biol. 2015 Jan;97(1):181-9. doi: 10.1189/jlb.5A0614-311R. Epub 2014 Nov 11.

PMID:
25387833
[PubMed - in process]
4.

CFP-10 from Mycobacterium tuberculosis Selectively Activates Human Neutrophils through a Pertussis Toxin-Sensitive Chemotactic Receptor.

Welin A, Björnsdottir H, Winther M, Christenson K, Oprea T, Karlsson A, Forsman H, Dahlgren C, Bylund J.

Infect Immun. 2015 Jan;83(1):205-13. doi: 10.1128/IAI.02493-14. Epub 2014 Oct 20.

PMID:
25332123
[PubMed - in process]
5.

A pepducin derived from the third intracellular loop of FPR2 is a partial agonist for direct activation of this receptor in neutrophils but a full agonist for cross-talk triggered reactivation of FPR2.

Gabl M, Winther M, Skovbakke SL, Bylund J, Dahlgren C, Forsman H.

PLoS One. 2014 Oct 10;9(10):e109516. doi: 10.1371/journal.pone.0109516. eCollection 2014.

PMID:
25303226
[PubMed - in process]
Free PMC Article
6.

Antibacterial activity of pepducins, allosterical modulators of formyl peptide receptor signaling.

Winther M, Gabl M, Oprea TI, Jönsson B, Boulay F, Bylund J, Dahlgren C, Forsman H.

Antimicrob Agents Chemother. 2014 May;58(5):2985-8. doi: 10.1128/AAC.02716-13. Epub 2014 Mar 3.

PMID:
24590483
[PubMed - in process]
Free PMC Article
7.

Measurement of respiratory burst products, released or retained, during activation of professional phagocytes.

Bylund J, Björnsdottir H, Sundqvist M, Karlsson A, Dahlgren C.

Methods Mol Biol. 2014;1124:321-38. doi: 10.1007/978-1-62703-845-4_21.

PMID:
24504962
[PubMed - indexed for MEDLINE]
8.

Collection of in vivo transmigrated neutrophils from human skin.

Christenson K, Björkman L, Davidsson L, Karlsson A, Follin P, Dahlgren C, Bylund J.

Methods Mol Biol. 2014;1124:39-52. doi: 10.1007/978-1-62703-845-4_4.

PMID:
24504945
[PubMed - indexed for MEDLINE]
9.

A novel receptor cross-talk between the ATP receptor P2Y2 and formyl peptide receptors reactivates desensitized neutrophils to produce superoxide.

Önnheim K, Christenson K, Gabl M, Burbiel JC, Müller CE, Oprea TI, Bylund J, Dahlgren C, Forsman H.

Exp Cell Res. 2014 Apr 15;323(1):209-17. doi: 10.1016/j.yexcr.2014.01.023. Epub 2014 Feb 1.

PMID:
24491917
[PubMed - indexed for MEDLINE]
10.

Patient and parental self-reports of executive functioning in a sample of young female adolescents with anorexia nervosa before and after cognitive remediation therapy.

Dahlgren CL, Lask B, Landrø NI, Rø Ø.

Eur Eat Disord Rev. 2014 Jan;22(1):45-52. doi: 10.1002/erv.2265. Epub 2013 Oct 16.

PMID:
24129969
[PubMed - indexed for MEDLINE]
11.

The human neutrophil subsets defined by the presence or absence of OLFM4 both transmigrate into tissue in vivo and give rise to distinct NETs in vitro.

Welin A, Amirbeagi F, Christenson K, Björkman L, Björnsdottir H, Forsman H, Dahlgren C, Karlsson A, Bylund J.

PLoS One. 2013 Jul 29;8(7):e69575. doi: 10.1371/journal.pone.0069575. Print 2013.

PMID:
23922742
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Neuropsychological functioning in adolescents with anorexia nervosa before and after cognitive remediation therapy: a feasibility trial.

Dahlgren CL, Lask B, Landrø NI, Rø Ø.

Int J Eat Disord. 2013 Sep;46(6):576-81. doi: 10.1002/eat.22155. Epub 2013 Jul 5.

PMID:
23828636
[PubMed - indexed for MEDLINE]
13.

Developing and evaluating cognitive remediation therapy (CRT) for adolescents with anorexia nervosa: A feasibility study.

Dahlgren CL, Lask B, Landrø NI, Rø O.

Clin Child Psychol Psychiatry. 2013 Jun 11;19(3):476-487. [Epub ahead of print]

PMID:
23761592
[PubMed - as supplied by publisher]
14.

Further studies on 2-arylacetamide pyridazin-3(2H)-ones: design, synthesis and evaluation of 4,6-disubstituted analogs as formyl peptide receptors (FPRs) agonists.

Giovannoni MP, Schepetkin IA, Cilibrizzi A, Crocetti L, Khlebnikov AI, Dahlgren C, Graziano A, Dal Piaz V, Kirpotina LN, Zerbinati S, Vergelli C, Quinn MT.

Eur J Med Chem. 2013 Jun;64:512-28. doi: 10.1016/j.ejmech.2013.03.066. Epub 2013 Apr 8.

PMID:
23685570
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

The leukocyte chemotactic receptor FPR2, but not the closely related FPR1, is sensitive to cell-penetrating pepducins with amino acid sequences descending from the third intracellular receptor loop.

Forsman H, Bylund J, Oprea TI, Karlsson A, Boulay F, Rabiet MJ, Dahlgren C.

Biochim Biophys Acta. 2013 Aug;1833(8):1914-23. doi: 10.1016/j.bbamcr.2013.03.026. Epub 2013 Apr 2.

PMID:
23562731
[PubMed - indexed for MEDLINE]
Free Article
16.

Reactivation of desensitized formyl peptide receptors by platelet activating factor: a novel receptor cross talk mechanism regulating neutrophil superoxide anion production.

Forsman H, Önnheim K, Andréasson E, Christenson K, Karlsson A, Bylund J, Dahlgren C.

PLoS One. 2013;8(3):e60169. doi: 10.1371/journal.pone.0060169. Epub 2013 Mar 28.

PMID:
23555913
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Structural characterization and inhibitory profile of formyl peptide receptor 2 selective peptides descending from a PIP2-binding domain of gelsolin.

Forsman H, Andréasson E, Karlsson J, Boulay F, Rabiet MJ, Dahlgren C.

J Immunol. 2012 Jul 15;189(2):629-37. doi: 10.4049/jimmunol.1101616. Epub 2012 Jun 15.

PMID:
22706076
[PubMed - indexed for MEDLINE]
Free Article
18.

Receptor-dependent and -independent immunomodulatory effects of phenol-soluble modulin peptides from Staphylococcus aureus on human neutrophils are abrogated through peptide inactivation by reactive oxygen species.

Forsman H, Christenson K, Bylund J, Dahlgren C.

Infect Immun. 2012 Jun;80(6):1987-95. doi: 10.1128/IAI.05906-11. Epub 2012 Mar 19.

PMID:
22431645
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

A non-peptide receptor inhibitor with selectivity for one of the neutrophil formyl peptide receptors, FPR 1.

Cevik-Aras H, Kalderén C, Jenmalm Jensen A, Oprea T, Dahlgren C, Forsman H.

Biochem Pharmacol. 2012 Jun 15;83(12):1655-62. doi: 10.1016/j.bcp.2012.02.024. Epub 2012 Mar 3.

PMID:
22410002
[PubMed - indexed for MEDLINE]
20.

Molecular docking of 2-(benzimidazol-2-ylthio)-N-phenylacetamide-derived small-molecule agonists of human formyl peptide receptor 1.

Khlebnikov AI, Schepetkin IA, Kirpotina LN, Brive L, Dahlgren C, Jutila MA, Quinn MT.

J Mol Model. 2012 Jun;18(6):2831-43. doi: 10.1007/s00894-011-1307-x. Epub 2011 Nov 30.

PMID:
22127612
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk